Gotowa bibliografia na temat „Vaccinia virus”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Vaccinia virus”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Vaccinia virus"
Tartaglia, James, i Enzo Paoletti. "Recombinant vaccinia virus vaccines". Trends in Biotechnology 6, nr 2 (luty 1988): 43–46. http://dx.doi.org/10.1016/0167-7799(88)90035-2.
Pełny tekst źródłaDoria-Rose, N. A., C. Ohlen, P. Polacino, C. C. Pierce, M. T. Hensel, L. Kuller, T. Mulvania i in. "Multigene DNA Priming-Boosting Vaccines Protect Macaques from Acute CD4+-T-Cell Depletion after Simian-Human Immunodeficiency Virus SHIV89.6P Mucosal Challenge". Journal of Virology 77, nr 21 (1.11.2003): 11563–77. http://dx.doi.org/10.1128/jvi.77.21.11563-11577.2003.
Pełny tekst źródłaKUTINOVA, L. "Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them". Vaccine 13, nr 5 (1995): 487–93. http://dx.doi.org/10.1016/0264-410x(94)00019-j.
Pełny tekst źródłaPrecopio, Melissa L., Michael R. Betts, Janie Parrino, David A. Price, Emma Gostick, David R. Ambrozak, Tedi E. Asher i in. "Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses". Journal of Experimental Medicine 204, nr 6 (29.05.2007): 1405–16. http://dx.doi.org/10.1084/jem.20062363.
Pełny tekst źródłaTruong, Cao-Sang, i So Young Yoo. "Oncolytic Vaccinia Virus in Lung Cancer Vaccines". Vaccines 10, nr 2 (4.02.2022): 240. http://dx.doi.org/10.3390/vaccines10020240.
Pełny tekst źródłaJacobs, Bertram L., Jeffrey O. Langland, Karen V. Kibler, Karen L. Denzler, Stacy D. White, Susan A. Holechek, Shukmei Wong, Trung Huynh i Carole R. Baskin. "Vaccinia virus vaccines: Past, present and future". Antiviral Research 84, nr 1 (październik 2009): 1–13. http://dx.doi.org/10.1016/j.antiviral.2009.06.006.
Pełny tekst źródłaSmith, Geoffrey L., Brendan J. Murphy i Mansun Law. "Vaccinia Virus Motility". Annual Review of Microbiology 57, nr 1 (październik 2003): 323–42. http://dx.doi.org/10.1146/annurev.micro.57.030502.091037.
Pełny tekst źródłaPerkus, M. E. "RECOMBINANT VACCINIA VIRUS". Pediatric Infectious Disease Journal 5, nr 2 (marzec 1986): 284. http://dx.doi.org/10.1097/00006454-198603000-00045.
Pełny tekst źródłaBroyles, Steven S. "Vaccinia virus transcription". Journal of General Virology 84, nr 9 (1.09.2003): 2293–303. http://dx.doi.org/10.1099/vir.0.18942-0.
Pełny tekst źródłaStittelaar, Koert J., Geert van Amerongen, Ivanela Kondova, Thijs Kuiken, Rob F. van Lavieren, Frank H. M. Pistoor, Hubert G. M. Niesters i in. "Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus". Journal of Virology 79, nr 12 (15.06.2005): 7845–51. http://dx.doi.org/10.1128/jvi.79.12.7845-7851.2005.
Pełny tekst źródłaRozprawy doktorskie na temat "Vaccinia virus"
Chan, Kenneth See Kit. "Nef from pathogenic simian immunodeficiency virus attenuates vaccinia virus /". For electronic version search Digital dissertations database. Restricted to UC campuses. Access is free to UC campus dissertations, 2004. http://uclibs.org/PID/11984.
Pełny tekst źródłaWallengren, Kristina. "Envelopment of retrovirus and vaccinia virus /". Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4851-8/.
Pełny tekst źródłaKettle, Susan. "Characterisation of vaccinia virus gene B13R". Thesis, University of Oxford, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.294390.
Pełny tekst źródłaMoore, Jeffrey B. "Vaccinia virus 3[beta]-hydroxysteroid dehydrogenase". Thesis, University of Oxford, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.359450.
Pełny tekst źródłaKeller, Brian Andrew. "Functional Genomic Studies of Vaccinia Virus Provide Fundamental Insights into Virus-Host Interactions". Thesis, Université d'Ottawa / University of Ottawa, 2017. http://hdl.handle.net/10393/36614.
Pełny tekst źródłaBleckwenn, Nicole Aleece. "Protein production development with recombinant vaccinia virus". College Park, Md. : University of Maryland, 2004. http://hdl.handle.net/1903/1416.
Pełny tekst źródłaThesis research directed by: Chemical Engineering. Title from t.p. of PDF. Includes bibliographical references. Published by UMI Dissertation Services, Ann Arbor, Mich. Also available in paper.
Gardner, Jeremy Damien. "Characterisation of the vaccinia virus gene A39R". Thesis, University of Oxford, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.365448.
Pełny tekst źródłaMajor, James R. "Interactions of dendritic cells with vaccinia virus". Thesis, University of Oxford, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.401096.
Pełny tekst źródłaOdell, Mark. "An analysis of vaccinia virus DNA ligase". Thesis, University of Oxford, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.670258.
Pełny tekst źródłaNapoli, Andrea. "Glycerophospholipid fluorescence imaging during vaccinia virus replication". Thesis, Sorbonne Paris Cité, 2019. https://theses.md.univ-paris-diderot.fr/NAPOLI_Andrea_1_va_20190415.pdf.
Pełny tekst źródłaVaccinia Virus (VACV) is the model organism for the study of the Poxviridae. Its cytoplasmic life cycle has been studied extensively by light- and electron microscopy. Thanks to a robust genetic system the role of some of its 250 proteins is beginning to be understood. Nevertheless, the acquisition of its membranes is still a matter of debate, in particular the role of cellular lipids. Lipid mass spectrometry of purified VACV previously showed an enrichment of phosphatidic acid (PA) and phosphatidylinositol derivatives (PIPs) in the viral membrane. Although some viral proteins have been shown to bind PIPs in vitro the role of these lipids in the viral life cycle, in particular viral membrane biogenesis, remains elusive.The aim of this work is to determine whether PA and PIPs are relocated in infected cells to the site of viral membrane biogenesis. For both PA and PIPs, I used recombinant proteins containing PA or PIP binding domains fused to eGFP, expressed them by transient transfection to follow their localization during viral replication. In addition, I used antibodies for the recognition of PI4K and PI4P. In order to understand the biochemical role of PIPs, I used pan-PI3K and PI4K inhibitors to study their effect on viral assembly. Using these tools, I could show that the lipids under investigation did not display an altered localization, with the exception of PI3P which showed a different pattern in infected cells. None of the PIPs analyzed co-localized with the sites of primary VACV membrane biogenesis. Consistent with the fact that the mature virus acquires additional membranes derived from the Golgi complex, I could show a co-localization of wrapped virus with PI4P, known to localize to this cellular organelle. However, drugs inhibiting PI3P and PI4P biosynthesis did not show any effect on VACV membrane biogenesis, at least at the light microscopy level. In conclusion, this work sharper defines the role of lipids during VACV replication. In particular, it opens the way to further studies on the putative role of PI4P during wrapping and the fate of PI3P and PI3P binding proteins during late replication
Książki na temat "Vaccinia virus"
Mercer, Jason, red. Vaccinia Virus. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9593-6.
Pełny tekst źródłaIsaacs, Stuart N., red. Vaccinia Virus and Poxvirology. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1385/1592597890.
Pełny tekst źródłaIsaacs, Stuart N., red. Vaccinia Virus and Poxvirology. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-876-4.
Pełny tekst źródłaBennett, Alice Marie. Co-expression of vaccine antigens in vaccinia virus. Manchester: University of Manchester, 1995.
Znajdź pełny tekst źródłaNeal, Isaacs Stuart, red. Vaccinia virus and poxvirology: Methods and protocols. Totowa, N.J: Humana Press, 2004.
Znajdź pełny tekst źródłaCarroll, Miles William. Expression analysis and immunogenicity of human immunodeficiency virus type 1 envelopeglycoprotein in vaccinia virus. Manchester: University of Manchester, 1993.
Znajdź pełny tekst źródłaXu, Fan. Construction of vaccinia virus recombinants carrying fragments of the rotavirus gene encoding VP7. [s.l.]: typescript, 1994.
Znajdź pełny tekst źródłaSchneider, Henriette. Rescue of measles virus using the vaccinia vector MVA-T7 & analysis of recombinant measles viruses mutated in the RNA editing site. [s.l.]: [s.n.], 1996.
Znajdź pełny tekst źródłaFerran, Maureen C., i Gary R. Skuse, red. Recombinant Virus Vaccines. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6869-5.
Pełny tekst źródła1919-, Fukai Kōnosuke, i Japan Intractable Diseases Research Foundation., red. Virus vaccines in Asian countries. [Tokyo]: University of Tokyo Press, 1986.
Znajdź pełny tekst źródłaCzęści książek na temat "Vaccinia virus"
Smith, G. L. "Recombinant vaccinia virus vaccines". W Recent Developments in Prophylactic Immunization, 313–33. Dordrecht: Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-1067-6_15.
Pełny tekst źródłaBartlett, D. L. "Vaccinia Virus". W Monographs in Virology, 130–59. Basel: KARGER, 2001. http://dx.doi.org/10.1159/000061723.
Pełny tekst źródłaShida, Hisatoshi. "Vaccinia Virus Hemagglutinin". W Subcellular Biochemistry, 405–40. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4899-1675-4_12.
Pełny tekst źródłaMoss, Bernard. "Vaccinia virus vectors". W Biotechnology for Solving Agricultural Problems, 317–23. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-4396-4_24.
Pełny tekst źródłaMoss, B. "Vaccinia Virus Vectors: Applications to Vaccines". W Progress in Immunology, 1131–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83755-5_151.
Pełny tekst źródłaSmith, Geoffrey L., i Alain Vanderplasschen. "Extracellular Enveloped Vaccinia Virus". W Advances in Experimental Medicine and Biology, 395–414. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5331-1_51.
Pełny tekst źródłaChalikonda, Sricharan, i David L. Bartlett. "Vaccinia and Pox-Virus". W Gene Therapy for Cancer, 73–85. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-222-9_4.
Pełny tekst źródłaMoss, Bernard. "Vaccinia Virus Expression Vectors". W Progress in Vaccinology, 415–21. New York, NY: Springer New York, 1989. http://dx.doi.org/10.1007/978-1-4612-3508-8_39.
Pełny tekst źródłaRooney, James F., Charles R. Wohlenberg i Abner Louis Notkins. "Vaccinia Virus Recombinants as Potential Herpes Simplex Virus Vaccines". W Genetically Engineered Vaccines, 183–89. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3410-5_20.
Pełny tekst źródłaIsaacs, Stuart N. "Working Safely with Vaccinia Virus". W Vaccinia Virus and Poxvirology, 1–13. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1385/1-59259-789-0:001.
Pełny tekst źródłaStreszczenia konferencji na temat "Vaccinia virus"
Protsenko, M. A., E. I. Filippova, E. V. Makarevich, I. A. Gorbunova, T. V. Teplyakova i N. A. Mazurkova. "ANTIVIRAL PROPERTIES OF EXTRACTS OF BASIDIOMYCETES OF THE NOVOSIBIRSK REGION". W X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-259.
Pełny tekst źródłaRaafat, Nermin, Chantal Mengus, Michael Heberer, Giulio C. Spagnoli i Paul Zajac. "Abstract 1500: Modulation of recombinant vaccinia virus vector immunogenicity". W Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1500.
Pełny tekst źródłaWang, Weiyi, Peihong Dai, Ning Yang, Stewart Shuman, Taha Merghoub, Jedd D. Wolchok i Liang Deng. "Abstract A007: Intratumoral delivery of inactivated vaccinia virus is more efficacious than live oncolytic vaccinia virus in murine bilateral tumor implantation models". W Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-a007.
Pełny tekst źródłaRamachandran, Mohanraj, i Magnus Essand. "Abstract B181: Adenovirus, Semliki Forest virus and vaccinia virus-induced immunogenic cell death augments oncolytic virus immunotherapy". W Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-b181.
Pełny tekst źródłaTrella, Emanuele. "Abstract A016: Multipotency of a CD40L-expressing recombinant vaccinia virus". W Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-a016.
Pełny tekst źródłaKonyakhina, Yu V., A. A. Sergeev, K. A. Titova, S. A. Pyankov, S. N. Yakubitskiy i S. N. Shchelkunov. "LOW-DOSE SMALLPOX VACCINATION IN A MOUSE MODEL". W X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-254.
Pełny tekst źródłaShulgina, I. S., S. N. Yakubitskiy, A. A. Sergeev, K. A. Titova, M. B. Borgoyakova, E. V. Starostina, L. I. Karpenko i S. N. Shchelkunov. "EFFECT OF THE ATI GENE DELETION ON PATHOGENICITY AND IMMUNOGENICITY OF THE VACCINIA VIRUS". W X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-268.
Pełny tekst źródłaKim, Jee Hung, Woo Sun Kwon, Tae Soo Kim, Kyu Hyun Park, Joong Bae Ahn, Namhee Lee, Ji Won Choi, Hyun Cheol Chung i Sun Young Rha. "Abstract B132: Antitumor effect of oncolytic vaccinia virus in gastric cancer". W Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1535-7163.targ-17-b132.
Pełny tekst źródłaPanopoulos, Evangelos, Emanuele Trella, Nermin Raafat, Chantal Mengus, Giulio Spagnoli i Paul Zajac. "Abstract 2843: Recombinant Vaccinia virus expressing CD40L: a multipotent antitumor immunogenic reagent." W Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2843.
Pełny tekst źródłaTIMIRYASOVA, TATYANA M., YONG A. YU, SHAHROKH SHABAHANG, ISTVAN FODOR i ALADAR A. SZALAY. "VISUALIZATION OF VACCINIA VIRUS INFECTION USING THE RENILLA-LUCIFERASE-GFP FUSION PROTEIN". W Proceedings of the 11th International Symposium. WORLD SCIENTIFIC, 2001. http://dx.doi.org/10.1142/9789812811158_0111.
Pełny tekst źródłaRaporty organizacyjne na temat "Vaccinia virus"
Buckley, Patricia E., Kevin P. O'Connell i Gary D. Ouellette. Review of Vaccinia Virus and Baculovirus Viability Versus Virucides. Fort Belvoir, VA: Defense Technical Information Center, marzec 2008. http://dx.doi.org/10.21236/ada480422.
Pełny tekst źródłaSchurig, Gerhardt G. Expression of Brucella Antigens in Vaccinia Virus to Prevent Brucellosis in Humans: Protection Studies in Mice. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2000. http://dx.doi.org/10.21236/ada382850.
Pełny tekst źródłaGates, Sean Damien. Biophysical analysis of bacterial and viral systems. A shock tube study of bio-aerosols and a correlated AFM/nanosims investigation of vaccinia virus. Office of Scientific and Technical Information (OSTI), maj 2013. http://dx.doi.org/10.2172/1108845.
Pełny tekst źródłaButler, Nadia, i Soha Karam. Evidence Review: COVID-19 Vaccine Acceptance by Key Influencers in the MENA Region - Teachers and Healthworkers. Institute of Development Studies (IDS), listopad 2021. http://dx.doi.org/10.19088/sshap.2021.039.
Pełny tekst źródłaGeisbert, Thomas W., i Peter B. Jahrling. Towards a Vaccine Against Ebola Virus. Fort Belvoir, VA: Defense Technical Information Center, styczeń 2003. http://dx.doi.org/10.21236/ada428607.
Pełny tekst źródłaKonakanchi, Lakshmi sravya. Vaccine Development for Respiratory Syncytial Virus. Ames (Iowa): Iowa State University, styczeń 2020. http://dx.doi.org/10.31274/cc-20240624-1577.
Pełny tekst źródłaVakharia, Vikram, Shoshana Arad, Yonathan Zohar, Yacob Weinstein, Shamila Yusuff i Arun Ammayappan. Development of Fish Edible Vaccines on the Yeast and Redmicroalgae Platforms. United States Department of Agriculture, luty 2013. http://dx.doi.org/10.32747/2013.7699839.bard.
Pełny tekst źródłaHeaton, Madeline. Review of Respiratory Syncytial Virus Vaccine Developments. Ames (Iowa): Iowa State University, maj 2022. http://dx.doi.org/10.31274/cc-20240624-1234.
Pełny tekst źródłaLublin, A., H. Ly, E. Porter, S. Mor, Y. Farnoushi i S. M. Goyal. Novel vaccination strategies to combat chicken arthritis/tenosynovitis reoviruses in US and Israel. Israel: United States-Israel Binational Agricultural Research and Development Fund, 2020. http://dx.doi.org/10.32747/2020.8134154.bard.
Pełny tekst źródłaTrent, Dennis W. Development of a Genetically Engineered Venezuelan Equine Encephalitis Virus Vaccine. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 1991. http://dx.doi.org/10.21236/ada237590.
Pełny tekst źródła